Company Filing History:
1 out of 1,381 
1 out of 2,893 
Years Active: 2015-2022
Title: Innovations of Mark W Tibbitt
Introduction
Mark W Tibbitt is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of photodegradable hydrogels and microparticles. With a total of 2 patents, Tibbitt's work focuses on innovative methods for cell capture and protein delivery.
Latest Patents
Tibbitt's latest patents include "Selective capture and release of rare mammalian cells using photodegradable hydrogels in a microfluidic platform." This invention discloses photodegradable hydrogels and associated kits designed for the selective capture and release of cells. The hydrogels are formed through cross-linking a macromer with a polymeric backbone and a cell-binding moiety, allowing for the detection of rare cell types in biological fluids.
Another significant patent is "Photodegradable groups for tunable polymeric materials." This patent presents a photodegradable microparticle system that can entrap and deliver bioactive proteins to cells during culture. The system enables a variety of spatiotemporally regulated release profiles, allowing researchers to explore how protein presentation can influence cell function.
Career Highlights
Throughout his career, Tibbitt has worked with esteemed institutions such as the University of Colorado and The General Hospital Corporation. His research has advanced the understanding of how materials can be engineered for biomedical applications, particularly in cell culture and protein delivery.
Collaborations
Tibbitt has collaborated with notable colleagues, including Kristi S Anseth and April M Kloxin. These partnerships have contributed to the innovative research and development of new materials and methods in the field.
Conclusion
Mark W Tibbitt's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in cell capture and protein delivery systems.